151 related articles for article (PubMed ID: 23342677)
1. Breast cancer drug warning.
Johns Hopkins Med Lett Health After 50; 2012 Dec; 24(11):8. PubMed ID: 23342677
[No Abstract] [Full Text] [Related]
2. Cardiotoxicity debated for anthracyclines and trastuzumab in breast cancer.
Brower V
J Natl Cancer Inst; 2013 Jun; 105(12):835-6. PubMed ID: 23733910
[No Abstract] [Full Text] [Related]
3. Screening for cardiac risk before anthracycline administration: what are the real benefits?
Ewer MS; Yang M; Buzdar AU
Clin Breast Cancer; 2012 Feb; 12(1):1-3. PubMed ID: 22130035
[No Abstract] [Full Text] [Related]
4. Cardiology patient page. Breast cancer chemotherapy and your heart.
Unitt C; Montazeri K; Tolaney S; Moslehi J
Circulation; 2014 Jun; 129(25):e680-2. PubMed ID: 24958758
[No Abstract] [Full Text] [Related]
5. Trastuzumab before breast surgery? Large trial says yes but does not quell debate.
Rowan K
J Natl Cancer Inst; 2009 Apr; 101(7):448-9. PubMed ID: 19318626
[No Abstract] [Full Text] [Related]
6. [Therapy concept: herceptin with anthracyclines].
Untch M
Onkologie; 2002 Dec; 25 Suppl 5():19-21; discussion 21. PubMed ID: 23573616
[No Abstract] [Full Text] [Related]
7. Women survive breast cancer but fall victim to heart failure: the shadows and lights of targeted therapy.
Maurea N; Coppola C; Ragone G; Frasci G; Bonelli A; Romano C; Iaffaioli RV
J Cardiovasc Med (Hagerstown); 2010 Dec; 11(12):861-8. PubMed ID: 20072001
[TBL] [Abstract][Full Text] [Related]
8. Trastuzumab and congestive heart failure: what can we learn from use in the community?
Geiger AM
J Natl Cancer Inst; 2012 Sep; 104(17):1269-70. PubMed ID: 22949431
[No Abstract] [Full Text] [Related]
9. Trastuzumab-related cardiotoxicity following anthracycline-based adjuvant chemotherapy: how worried should we be?
Morris PG; Hudis CA
J Clin Oncol; 2010 Jul; 28(21):3407-10. PubMed ID: 20530269
[No Abstract] [Full Text] [Related]
10. Cardiac issues related to trastuzumab.
Perez EA
Breast; 2004 Jun; 13(3):171-2. PubMed ID: 15177417
[No Abstract] [Full Text] [Related]
11. Heart of darkness: the downside of trastuzumab.
Hayes DF; Picard MH
J Clin Oncol; 2006 Sep; 24(25):4056-8. PubMed ID: 16908930
[No Abstract] [Full Text] [Related]
12. [Congestive heart failure].
Asakura M
Nihon Rinsho; 2012 Aug; 70 Suppl 6():580-4. PubMed ID: 23156576
[No Abstract] [Full Text] [Related]
13. Bevacizumab and heart failure risk in patients with breast cancer: a thorn in the side?
Verma N; Swain SM
J Clin Oncol; 2011 Feb; 29(6):603-6. PubMed ID: 21205751
[No Abstract] [Full Text] [Related]
14. Cancer drug may cause heart failure.
Gottlieb S
BMJ; 2000 Jul; 321(7256):259. PubMed ID: 10915118
[No Abstract] [Full Text] [Related]
15. Cardiotoxic effects of trastuzumab.
Hysing J; Wist E
Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2239-41. PubMed ID: 22085949
[TBL] [Abstract][Full Text] [Related]
16. Clinical cardiac tolerability of trastuzumab.
Perez EA; Rodeheffer R
J Clin Oncol; 2004 Jan; 22(2):322-9. PubMed ID: 14722042
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxicity associated with trastuzumab and chemotherapy used for HER2-positive cancers.
Mardis C
MLO Med Lab Obs; 2014 Apr; 46(4):18, 20. PubMed ID: 24783682
[No Abstract] [Full Text] [Related]
18. Choosing the best trastuzumab-based adjuvant chemotherapy regimen: should we abandon anthracyclines?
Burstein HJ; Piccart-Gebhart MJ; Perez EA; Hortobagyi GN; Wolmark N; Albain KS; Norton L; Winer EP; Hudis CA
J Clin Oncol; 2012 Jun; 30(18):2179-82. PubMed ID: 22614986
[No Abstract] [Full Text] [Related]
19. Cardiotoxicity of systemic agents used in breast cancer.
Ades F; Zardavas D; Pinto AC; Criscitiello C; Aftimos P; de Azambuja E
Breast; 2014 Aug; 23(4):317-28. PubMed ID: 24794210
[TBL] [Abstract][Full Text] [Related]
20. Anthracyclines and trastuzumab; getting to the heart of the matter: when getting to the heart is the matter.
Morris PG; Hudis CA
Breast Cancer Res Treat; 2011 Jun; 127(2):585-6. PubMed ID: 18791822
[No Abstract] [Full Text] [Related]
[Next] [New Search]
